Beste apotheek van Nederland

Moncada I, Jara J, Subira D et al. Efficacy of sildenafil citrate at
12 hours after dosing: re-exploring the therapeutic window. Eur
Urol 2004;46(3):357-360.
Montorsi F, Althof S E. Partner responses to sildenafil citrate
(Viagra) treatment of erectile dysfunction. Urology
2004;63(4):762-767.
Montorsi F, McCullough A. Efficacy of sildenafil citrate in men
with erectile dysfunction following radical prostatectomy: A
systematic review of clinical data. Br J Sex Med 2005;2(5):658­
667.
Montorsi F, Althof S E, Sweeney M et al. Treatment satisfaction
in patients with erectile dysfunction switching from
prostaglandin E(1) intracavernosal injection therapy to oral
sildenafil citrate. Int J Impot Res 2003;15(6):444-449.
Montorsi F, Briganti A, Salonia A et al. Can Phosphodiesterase
Type 5 Inhibitors Cure Erectile Dysfunction?. Eur Urol
2006;49(6):979-986.
Montorsi F, Guazzoni G, Barbieri L et al. The effect of
intracorporeal injection plus genital and audiovisual sexual
stimulation versus second injection on penile color Doppler
sonography parameters. Br J Urol 1996;155(2):536-540.
Montorsi F, Guazzoni G, Bergamaschi F et al. Effectiveness and
safety of multidrug intracavernous therapy for vasculogenic
impotence. Urology 1993;42(5):554-558.
Montorsi F, Guazzoni G, Bergamaschi F et al. Four-drug
intracavernous therapy for impotence due to corporeal venoocclusive
dysfunction. Br J Urol 1993;149(5 Pt 2):1291-1295.
Montorsi F, Guazzoni G, Bergamaschi F et al. Intracavernous
vasoactive pharmacotherapy: the impact of a new self-injection
device.[see comment]. Br J Urol 1993;150(6):1829-1832.
Montorsi F, Guazzoni G, Bergamaschi F et al. Clinical
reliability of multi-drug intracavernous vasoactive
pharmacotherapy for diabetic impotence. Acta Diabetol Lat
1994;31(1):1-5.
Montorsi F, Hellstrom W J, Valiquette L et al. Vardenafil
provides reliable efficacy over time in men with erectile
dysfunction. Urology 2004;64(6):1187-1195.
Montorsi F, Perani D, Anchisi D et al. Apomorphine-induced
brain modulation during sexual stimulation: a new look at
central phenomena related to erectile dysfunction. Int J Impot
Res 2003;15(3):203-209.
Montorsi F, Salonia A, Briganti A et al. Vardenafil for the
treatment of erectile dysfunction: A critical review of the
literature based on personal clinical experience. Eur Urol
2005;47(5):612-621.
Montorsi F, Verheyden B, Meuleman E et al. Long-term safety
and tolerability of tadalafil in the treatment of erectile
dysfunction. Eur Urol 2004;45(3):339-344.
Moore R A, Derry S, McQuay H J. Indirect
comparison of interventions using published
randomised trials: systematic review of PDE-5
inhibitors for erectile dysfunction. [Review] [77 refs].
BMC Urol 2005;518
Moore R A, Edwards J E, McQuay H J. Sildenafil
(Viagra) for male erectile dysfunction: a meta-analysis
of clinical trial reports. BMC Urol. 2002;26
Morales A, Gingell C, Collins M et al. Clinical safety
of oral sildenafil citrate (VIAGRA) in the treatment of
erectile dysfunction. Int J Impot Res 1998;10(2):69­
73.
Morales A, Johnston B, Heaton J P et al. Testosterone
supplementation for hypogonadal impotence:
assessment of biochemical measures and therapeutic
outcomes. Br J Urol 1997;157(3):849-854.
Morales A, Johnston B, Heaton J W et al. Oral
androgens in the treatment of hypogonadal impotent
men.[see comment]. Br J Urol 1994;152(4):1115­
1118.
Morgentaler A, Barada J, Niederberger C et al.
Efficacy and safety of tadalafil across ethnic groups
and various risk factors in men with erectile
dysfunction: Use of a novel noninferiority study
design. Br J Sex Med 2006;3(3):492-503.
Mulhall J P. Deciphering erectile dysfunction drug
trials. [Review] [35 refs]. Br J Urol 2003;170(2 Pt
1):353-358.
Mulhall J P. Sublingual apomorphine for the treatment
of erectile dysfunction. [Review] [22 refs]. Expert
Opin Investig Drugs 2002;11(2):295-302.
Mulhall J P, Bukofzer S, Edmonds A L et al. An openlabel,
uncontrolled dose-optimization study of
sublingual apomorphine in erectile dysfunction. Clin
Ther 2001;23(8):1260-1271.
Mulhall J P, Guhring P, Parker M et al. Assessment of
the impact of sildenafil citrate on lower urinary tract
symptoms in men with erectile dysfunction. Br J Sex
Med 2006;3(4):662-667.
Mulhall J P, Jahoda A E, Ahmed A et al. Analysis of
the consistency of intraurethral prostaglandin E(1)
(MUSE) during at-home use. Urology
2001;58(2):262-266.
Mulhall J P, Jahoda A E, Cairney M et al. The causes
of patient dropout from penile self-injection therapy
for impotence. Br J Urol 1999;162(4):1291-1294.
Mulhall J P, Jahoda A, Aviv N et al. The impact of
sildenafil citrate on sexual satisfaction profiles in men
with a penile prosthesis in situ. BJU Int
2004;93(1):97-99.
D-114